Population homogeneity for the antibody response to COVID-19 BNT162b2 / Comirnaty vaccine is only reached after the second dose, across all adult age ranges
João F. Viana, View ORCID ProfileMarie-Louise Bergman, Lígia A. Gonçalves, View ORCID ProfileNádia Duarte, Teresa Penha Coutinho, Patrícia C. Borges, Christian Diwo, View ORCID ProfileRute Castro, Paula Matoso, Vanessa Malheiro, Ana Brennand, Lindsay Kosack, View ORCID ProfileOnome Akpogheneta, João M. Figueira, Conceição Cardoso, Ana M. Casaca, Paula M. Alves, Telmo Nunes, View ORCID ProfileCarlos Penha-Gonçalves, View ORCID ProfileJocelyne Demengeot
doi: https://doi.org/10.1101/2021.03.19.21253680
João F. Viana
1CHLO, Centro Hospitalar de Lisboa Ocidental, Serviço de Patologia Clínica, Lisbon, 1449-005, Portugal
Marie-Louise Bergman
2IGC, Instituto Gulbenkian de Ciência, Oeiras, 2780-156, Portugal
Lígia A. Gonçalves
2IGC, Instituto Gulbenkian de Ciência, Oeiras, 2780-156, Portugal
Nádia Duarte
2IGC, Instituto Gulbenkian de Ciência, Oeiras, 2780-156, Portugal
Teresa Penha Coutinho
3CIISA, Centre for Interdisciplinary Research in Animal Health, Faculty of Veterinary Medicine, University of Lisbon, Lisbon,1300-477, Portugal
Patrícia C. Borges
2IGC, Instituto Gulbenkian de Ciência, Oeiras, 2780-156, Portugal
Christian Diwo
2IGC, Instituto Gulbenkian de Ciência, Oeiras, 2780-156, Portugal
Rute Castro
3CIISA, Centre for Interdisciplinary Research in Animal Health, Faculty of Veterinary Medicine, University of Lisbon, Lisbon,1300-477, Portugal
Paula Matoso
2IGC, Instituto Gulbenkian de Ciência, Oeiras, 2780-156, Portugal
Vanessa Malheiro
2IGC, Instituto Gulbenkian de Ciência, Oeiras, 2780-156, Portugal
Ana Brennand
2IGC, Instituto Gulbenkian de Ciência, Oeiras, 2780-156, Portugal
Lindsay Kosack
2IGC, Instituto Gulbenkian de Ciência, Oeiras, 2780-156, Portugal
Onome Akpogheneta
2IGC, Instituto Gulbenkian de Ciência, Oeiras, 2780-156, Portugal
João M. Figueira
1CHLO, Centro Hospitalar de Lisboa Ocidental, Serviço de Patologia Clínica, Lisbon, 1449-005, Portugal
Conceição Cardoso
1CHLO, Centro Hospitalar de Lisboa Ocidental, Serviço de Patologia Clínica, Lisbon, 1449-005, Portugal
Ana M. Casaca
1CHLO, Centro Hospitalar de Lisboa Ocidental, Serviço de Patologia Clínica, Lisbon, 1449-005, Portugal
Paula M. Alves
4IBET, Instituto de Biologia Experimental e Tecnológica, Oeiras, 2780-901, Portugal
5ITQB NOVA, Instituto de Tecnológia Química e Biológica António Xavier, Universidade Nova de Lisboa, Oeiras, 2780-157, Portugal
Telmo Nunes
3CIISA, Centre for Interdisciplinary Research in Animal Health, Faculty of Veterinary Medicine, University of Lisbon, Lisbon,1300-477, Portugal
Carlos Penha-Gonçalves
2IGC, Instituto Gulbenkian de Ciência, Oeiras, 2780-156, Portugal
Jocelyne Demengeot
2IGC, Instituto Gulbenkian de Ciência, Oeiras, 2780-156, Portugal
![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Data Availability
Anonymised raw data for Ig levels will be made available on demand. Biometric data will not be shared.
Posted June 04, 2021.
Population homogeneity for the antibody response to COVID-19 BNT162b2 / Comirnaty vaccine is only reached after the second dose, across all adult age ranges
João F. Viana, Marie-Louise Bergman, Lígia A. Gonçalves, Nádia Duarte, Teresa Penha Coutinho, Patrícia C. Borges, Christian Diwo, Rute Castro, Paula Matoso, Vanessa Malheiro, Ana Brennand, Lindsay Kosack, Onome Akpogheneta, João M. Figueira, Conceição Cardoso, Ana M. Casaca, Paula M. Alves, Telmo Nunes, Carlos Penha-Gonçalves, Jocelyne Demengeot
medRxiv 2021.03.19.21253680; doi: https://doi.org/10.1101/2021.03.19.21253680
Population homogeneity for the antibody response to COVID-19 BNT162b2 / Comirnaty vaccine is only reached after the second dose, across all adult age ranges
João F. Viana, Marie-Louise Bergman, Lígia A. Gonçalves, Nádia Duarte, Teresa Penha Coutinho, Patrícia C. Borges, Christian Diwo, Rute Castro, Paula Matoso, Vanessa Malheiro, Ana Brennand, Lindsay Kosack, Onome Akpogheneta, João M. Figueira, Conceição Cardoso, Ana M. Casaca, Paula M. Alves, Telmo Nunes, Carlos Penha-Gonçalves, Jocelyne Demengeot
medRxiv 2021.03.19.21253680; doi: https://doi.org/10.1101/2021.03.19.21253680
Subject Area
Subject Areas
- Addiction Medicine (339)
- Allergy and Immunology (665)
- Anesthesia (179)
- Cardiovascular Medicine (2621)
- Dermatology (220)
- Emergency Medicine (396)
- Epidemiology (12163)
- Forensic Medicine (10)
- Gastroenterology (754)
- Genetic and Genomic Medicine (4054)
- Geriatric Medicine (383)
- Health Economics (674)
- Health Informatics (2617)
- Health Policy (996)
- Hematology (359)
- HIV/AIDS (840)
- Medical Education (397)
- Medical Ethics (109)
- Nephrology (429)
- Neurology (3824)
- Nursing (208)
- Nutrition (569)
- Oncology (2004)
- Ophthalmology (580)
- Orthopedics (238)
- Otolaryngology (303)
- Pain Medicine (250)
- Palliative Medicine (73)
- Pathology (470)
- Pediatrics (1107)
- Primary Care Research (445)
- Public and Global Health (6495)
- Radiology and Imaging (1385)
- Respiratory Medicine (868)
- Rheumatology (399)
- Sports Medicine (338)
- Surgery (440)
- Toxicology (52)
- Transplantation (185)
- Urology (165)